Why These 5 Stocks Are Trending on Tuesday

3. CureVac N.V. (NASDAQ:CVAC) is down 6.3% after the company decided not to proceed with the development of its most advanced vaccine candidate for COVID-19. CureVac N.V. (NASDAQ:CVAC)’s vaccine candidate’s efficacy was not comparable to Pfizer’s. The number of elite funds long CureVac N.V. (NASDAQ:CVAC) rose by 3 from the prior quarter to 12 at the end of the second quarter.